Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Flaten's Stock Ratings
Lake Street Analyst
Thomas Flaten is an analyst at Lake Street. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/17/2025
Overall Average Return
-17.7%
Smart Score
Overall Average Return Percentile
15th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/28/2025 | OCX | Buy Now | OncoCyte | $2.90 | 72.41% | Thomas Flaten36% | → $5 | Initiates | → Buy | Get Alert |
| 03/20/2025 | OPTN | Buy Now | OptiNose | $9.03 | -0.33% | Thomas Flaten36% | $17 → $9 | Downgrade | Buy → Hold | Get Alert |
| 03/10/2025 | CKPT | Buy Now | Checkpoint Therapeutics | $4.03 | 1.74% | Thomas Flaten36% | $7 → $4.1 | Downgrade | Buy → Hold | Get Alert |
| 03/07/2025 | AQST | Buy Now | Aquestive Therapeutics | $2.51 | 218.73% | Thomas Flaten36% | $10 → $8 | Maintains | Buy | Get Alert |
| 02/04/2025 | EVAX | Buy Now | Evaxion Biotech | $1.31 | 358.02% | Thomas Flaten36% | $35 → $6 | Maintains | Buy | Get Alert |
| 01/16/2025 | OPTN | Buy Now | OptiNose | $9.03 | 88.26% | Thomas Flaten36% | $45 → $17 | Maintains | Buy | Get Alert |
| 01/08/2025 | PSNL | Buy Now | Personalis | $3.19 | 182.13% | Thomas Flaten36% | $7 → $9 | Maintains | Buy | Get Alert |
| 12/16/2024 | CKPT | Buy Now | Checkpoint Therapeutics | $4.03 | 73.7% | Thomas Flaten36% | $4 → $7 | Maintains | Buy | Get Alert |
| 11/05/2024 | CSTL | Buy Now | Castle Biosciences | $21.51 | 85.96% | Thomas Flaten36% | $34 → $40 | Maintains | Buy | Get Alert |
| 09/06/2024 | DERM | Buy Now | Journey Medical | $6.10 | 47.54% | Thomas Flaten36% | → $9 | Initiates | → Buy | Get Alert |
| 05/15/2024 | OPTN | Buy Now | OptiNose | $9.03 | -66.78% | Thomas Flaten36% | $60 → $45 | Maintains | Buy | Get Alert |
| 04/30/2024 | PSNL | Buy Now | Personalis | $3.19 | 25.39% | Thomas Flaten36% | → $4 | Initiates | → Buy | Get Alert |
| 04/19/2024 | DMTK | Buy Now | DermTech | — | — | Thomas Flaten36% | → $0.63 | Downgrade | Buy → Hold | Get Alert |
| 03/18/2024 | OPTN | Buy Now | OptiNose | $9.03 | -55.7% | Thomas Flaten36% | $45 → $60 | Maintains | Buy | Get Alert |
| 03/12/2024 | ASRT | Buy Now | Assertio Holdings | $0.61 | 391.48% | Thomas Flaten36% | $4 → $3 | Maintains | Buy | Get Alert |
| 03/07/2024 | AQST | Buy Now | Aquestive Therapeutics | $2.51 | 218.73% | Thomas Flaten36% | $3 → $8 | Maintains | Buy | Get Alert |
| 03/05/2024 | ACHV | Buy Now | Achieve Life Sciences | $1.99 | 452.76% | Thomas Flaten36% | $19 → $11 | Maintains | Buy | Get Alert |
| 08/21/2023 | OPTN | Buy Now | OptiNose | $9.03 | -66.78% | Thomas Flaten36% | → $45 | Initiates | → Buy | Get Alert |
| 08/16/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.03 | 247.39% | Thomas Flaten36% | $16 → $14 | Maintains | Buy | Get Alert |
| 08/10/2023 | BTTX | Buy Now | Better Therapeutics | $0.00 | 749900% | Thomas Flaten36% | $5 → $3 | Maintains | Buy | Get Alert |
| 08/09/2023 | BLFS | Buy Now | BioLife Solns | $21.91 | 14.1% | Thomas Flaten36% | $34 → $25 | Maintains | Buy | Get Alert |
| 07/07/2023 | CSTL | Buy Now | Castle Biosciences | $21.51 | 48.77% | Thomas Flaten36% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | CSTL | Buy Now | Castle Biosciences | $21.51 | 48.77% | Thomas Flaten36% | $41 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | ACHV | Buy Now | Achieve Life Sciences | $1.99 | 854.77% | Thomas Flaten36% | $22 → $19 | Maintains | Buy | Get Alert |
| 05/30/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.03 | 297.02% | Thomas Flaten36% | $22 → $16 | Maintains | Buy | Get Alert |
| 05/10/2023 | ACHV | Buy Now | Achieve Life Sciences | $1.99 | 1005.53% | Thomas Flaten36% | → $22 | Maintains | Buy | Get Alert |
| 05/10/2023 | ASRT | Buy Now | Assertio Holdings | $0.61 | 1374.44% | Thomas Flaten36% | $8 → $9 | Maintains | Buy | Get Alert |
| 04/14/2023 | BTTX | Buy Now | Better Therapeutics | $0.00 | 1249900% | Thomas Flaten36% | $6 → $5 | Maintains | Buy | Get Alert |
| 04/04/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.03 | 445.91% | Thomas Flaten36% | $32 → $22 | Maintains | Buy | Get Alert |
| 03/31/2023 | EVAX | Buy Now | Evaxion Biotech | $1.31 | 434.35% | Thomas Flaten36% | $1800 → $700 | Maintains | Buy | Get Alert |
| 12/01/2022 | OCX | Buy Now | OncoCyte | $2.90 | -82.76% | Thomas Flaten36% | $60 → $10 | Downgrade | Buy → Hold | Get Alert |
| 11/17/2022 | ENSC | Buy Now | Ensysce Biosciences | $1.79 | 346.93% | Thomas Flaten36% | $14400 → $1440 | Maintains | Buy | Get Alert |
| 11/07/2022 | ASRT | Buy Now | Assertio Holdings | $0.61 | 1046.79% | Thomas Flaten36% | → $7 | Initiates | → Buy | Get Alert |
| 08/11/2022 | OCX | Buy Now | OncoCyte | $2.90 | 3.45% | Thomas Flaten36% | $120 → $60 | Maintains | Buy | Get Alert |
| 07/07/2022 | DMAC | Buy Now | DiaMedica Therapeutics | $3.24 | 146.91% | Thomas Flaten36% | $14 → $8 | Maintains | Buy | Get Alert |
| 05/13/2022 | BBI | Buy Now | Brickell Biotech | — | — | Thomas Flaten36% | — | Downgrade | Buy → Hold | Get Alert |
| 03/11/2022 | OCX | Buy Now | OncoCyte | $2.90 | 106.9% | Thomas Flaten36% | $220 → $120 | Maintains | Buy | Get Alert |
| 03/01/2022 | CSTL | Buy Now | Castle Biosciences | $21.51 | 192.89% | Thomas Flaten36% | $94 → $63 | Maintains | Buy | Get Alert |
| 11/30/2021 | ENSC | Buy Now | Ensysce Biosciences | $1.79 | 123.46% | Thomas Flaten36% | → $14400 | Initiates | → Buy | Get Alert |
| 04/30/2021 | CSTL | Buy Now | Castle Biosciences | $21.51 | 337.01% | Thomas Flaten36% | → $94 | Initiates | → Buy | Get Alert |
| 08/28/2020 | BBI | Buy Now | Brickell Biotech | — | — | Thomas Flaten36% | → $270 | Initiates | → Buy | Get Alert |
| 02/24/2020 | BLFS | Buy Now | BioLife Solns | $21.91 | 14.1% | Thomas Flaten36% | → $25 | Initiates | → Buy | Get Alert |
| 03/24/2016 | OCX | Buy Now | OncoCyte | $2.90 | — | Thomas Flaten36% | — | Initiates | → Buy | Get Alert |
